-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Adial Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
- Adial Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$171K, a 427% decline year-over-year.
- Adial Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$114K, a 280% decline from 2022.
- Adial Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $63.3K.
- Adial Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$229K, a 753% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)